Aortech International PLC
13 July 2000
AGM Statement
At the Annual General Meeting of Aortech International held
today the Chairman Gordon Wright said:
'As you will have seen from our Annual Report, the year to 31st
March saw major strategic and corporate developments in the
Aortech Group, which included the extension of our present
range of cardio vascular products, and significant
technological and regulatory advances in our new products and
projects.
I can report that the product development and the trials of the
new tri-leaf polymer valve are proceeding according to plan,
and we continue on course to commence patient trials in the
latter half of next year. Our plans for the commercialisation
of the TruCOMMS cardiac output monitor are on course, including
the marketing of the system in the USA.
Our acquisition of ElastoMedic in Australia is working out
extremely well, and there is increasing interest in the Elast-
Eon material which featured in a number of papers presented to
World's major bio-materials conference in Hawaii in May.
As you all know, we had a successful fund raising and Open
Offer of new shares in February, which was not only well
supported by existing shareholders - both institutional
investors and individuals - but gave us the opportunity to
welcome a number of major new investors to Aortech.
I believe that the potential of these world leading
technologies: the Elast-Eon material, the new Tri-leaflet heart
valve, and the cardiac monitoring system together will ensure
AorTech's ongoing strength in the global medical devices and
materials sectors in future years.'
All resolutions proposed at the AGM were duly passed.
13th July 2000
Enquiries:
AorTech International plc Tel: 01698 746699
Eddie McDaid, Managing Director
College Hill Tel: 020 7457 2020
Michael Padley
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.